Summary
University of Cambridge (UC) is an educational and research institute that offers undergraduate and graduate studies. The institute offers undergraduate courses in areas of architecture, chemical engineering, classics, computer science, economics, education, engineering, English, land economy, law, linguistics, natural sciences, human, social, and political sciences, veterinary medicine, theology and religious studies, philosophy, psychological and behavioral sciences, mathematics, medicine and management studies. It provides undergraduate program through its affiliated colleges. The institute also conducts research programs on infectious diseases, cancer, biological and biomedical sciences. UC is headquartered in Cambridge, the UK.
University of Cambridge - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
University of Cambridge, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
University of Cambridge, Medical Devices Deals, 2010 to YTD 2016 10
University of Cambridge, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
University of Cambridge, Pharmaceuticals & Healthcare, Deal Details 15
Venture Financing 15
Carrick Therapeutics Raises USD95 Million in Venture Financing 15
DefiniGEN Raises USD2.2 Million in Venture Financing 17
Cambridge Epigenetix Raises USD21 Million in Series B Financing 19
Morphogen-IX Raises USD2 Million in Seed Financing 20
Quethera Raises Funds in Seed Financing Round 21
Fluidic Analytics Raises USD7 Million in Series B Financing 22
PhoreMost Raises USD3.8 Million in Seed Financing 24
Fluidic Analytics Raises USD2.4 Million in Series A Venture Financing 25
Cambridge Epigenetix Raises USD5.5 Million in Series A Venture Financing 27
DefiniGEN Raises USD3.8 Million in Series A Financing 28
Horizon Discovery Raises US$10.5 Million In Final Closing Of Series C Financing 30
Sphere Fluidics Raises US$2.5 Million In Venture Financing 32
Sphere Fluidics Raises Funds through Seed Financing 34
Partnerships 35
PhoreMost Enters into Research Agreement with University of Cambridge 35
Genestack Partners with Cancer Molecular Diagnostic Laboratory 36
OncoTherics Enters into Agreement with University of Cambridge 37
AstraZeneca and MedImmune Enter into R&D Agreement with University of Cambridge 38
MedImmune Enters Into Research Agreement With Cambridge University 40
GlaxoSmithKline Enters Into Co-Development Agreement With University of Cambridge 41
University of Cambridge Enters Into Joint Venture Agreement With Elan 42
Phylogica Enters Into Joint Venture Agreement With University Of Cambridge 43
AstraZeneca Enters Into Joint Venture With Sanofi, University Of Cambridge, EPFL, And Universities Of Pavia And Uppsala 44
Licensing Agreements 46
Cantabio Pharma Enters into Licensing Agreement with University of Cambridge 46
DefiniGEN Enters into Licensing Agreement with University of Cambridge 47
Sphere Fluidics Enters Into Licensing Agreement with Cambridge University for Picodroplets 48
Sphere Fluidics Enters Into Licensing Agreement with Cambridge University 49
Acquisition 50
Nihon Trim To Acquire 50.1% Stake In StemCell Institute For US$5.3 Million 50
SuperGen Completes Acquisition Of Astex Therapeutics 51
University of Cambridge - Key Competitors 55
Key Employees 56
Locations And Subsidiaries 57
Head Office 57
Other Locations & Subsidiaries 57
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
List of Tables
University of Cambridge, Pharmaceuticals & Healthcare, Key Facts 1
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
University of Cambridge, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
University of Cambridge, Deals By Therapy Area, 2010 to YTD 2016 9
University of Cambridge, Medical Devices Deals, 2010 to YTD 2016 10
University of Cambridge, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Carrick Therapeutics Raises USD95 Million in Venture Financing 15
DefiniGEN Raises USD2.2 Million in Venture Financing 17
Cambridge Epigenetix Raises USD21 Million in Series B Financing 19
Morphogen-IX Raises USD2 Million in Seed Financing 20
Quethera Raises Funds in Seed Financing Round 21
Fluidic Analytics Raises USD7 Million in Series B Financing 22
PhoreMost Raises USD3.8 Million in Seed Financing 24
Fluidic Analytics Raises USD2.4 Million in Series A Venture Financing 25
Cambridge Epigenetix Raises USD5.5 Million in Series A Venture Financing 27
DefiniGEN Raises USD3.8 Million in Series A Financing 28
Horizon Discovery Raises US$10.5 Million In Final Closing Of Series C Financing 30
Sphere Fluidics Raises US$2.5 Million In Venture Financing 32
Sphere Fluidics Raises Funds through Seed Financing 34
PhoreMost Enters into Research Agreement with University of Cambridge 35
Genestack Partners with Cancer Molecular Diagnostic Laboratory 36
OncoTherics Enters into Agreement with University of Cambridge 37
AstraZeneca and MedImmune Enter into R&D Agreement with University of Cambridge 38
MedImmune Enters Into Research Agreement With Cambridge University 40
GlaxoSmithKline Enters Into Co-Development Agreement With University of Cambridge 41
University of Cambridge Enters Into Joint Venture Agreement With Elan 42
Phylogica Enters Into Joint Venture Agreement With University Of Cambridge 43
AstraZeneca Enters Into Joint Venture With Sanofi, University Of Cambridge, EPFL, And Universities Of Pavia And Uppsala 44
Cantabio Pharma Enters into Licensing Agreement with University of Cambridge 46
DefiniGEN Enters into Licensing Agreement with University of Cambridge 47
Sphere Fluidics Enters Into Licensing Agreement with Cambridge University for Picodroplets 48
Sphere Fluidics Enters Into Licensing Agreement with Cambridge University 49
Nihon Trim To Acquire 50.1% Stake In StemCell Institute For US$5.3 Million 50
SuperGen Completes Acquisition Of Astex Therapeutics 51
University of Cambridge, Key Competitors 55
University of Cambridge, Key Employees 56
University of Cambridge, Other Locations 57
University of Cambridge, Subsidiaries 58
List of Figures
University of Cambridge, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
University of Cambridge, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
University of Cambridge, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
University of Cambridge, Medical Devices Deals, 2010 to YTD 2016 10
